TL;DR: Aetna reaffirmed and modified CPB 0820 on March 4, 2026, classifying all carotid sinus stimulation for hypertension as experimental and non-covered. Every CPT code in this category — 0266T through 0273T, 64654 through 64659, and HCPCS C1825 — is denied for both hypertension and heart failure indications.
If your billing team submits claims for baroreflex activation therapy (BAT) against Aetna policies, this coverage policy update means automatic denial. Here's what you need to know before billing another claim.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna |
| Policy | Carotid Sinus Stimulation for Hypertension |
| Policy Code | CPB 0820 |
| Change Type | Modified |
| Effective Date | 2026-03-04 |
| Impact Level | High — 14 CPT codes and one HCPCS code are fully non-covered |
| Specialties Affected | Not specified in policy source |
| Key Action | Flag CPT codes 0266T–0273T and 64654–64659 as non-covered in your charge master before submitting any Aetna claims |
Aetna Carotid Sinus Stimulation Coverage Criteria and Medical Necessity Requirements 2026
There are no coverage criteria that make carotid sinus stimulation billable to Aetna. That's the point.
Aetna's CPB 0820 coverage policy draws a hard line: implantable carotid sinus stimulators do not meet medical necessity under any documented indication. The Barostim neo™ System and the Rheos Baroreflex Hypertension Therapy System are both explicitly named. The policy denies reimbursement for treatment of hypertension and all other uses, including heart failure.
Magnetic stimulation of the carotid sinus gets the same treatment. Aetna considers it experimental and unproven for hypertension — full stop.
CPB 0820 classifies these procedures as experimental and investigational. Consult your payer contract and compliance team regarding prior authorization workflows before submitting any claims in this category.
The real risk for billing teams is submitting these codes and expecting adjudication on medical necessity grounds. Aetna's position isn't "prove it's medically necessary." It's "we don't recognize this procedure as established." That's a different denial category, and it requires a different appeals strategy.
Aetna Carotid Sinus Stimulation Exclusions and Non-Covered Indications
Every indication in this policy is non-covered. That's an unusual situation, and your billing team needs to understand the scope.
Aetna excludes carotid sinus stimulation for two categories of patients: those with hypertension (ICD-10 I10–I16.9) and those with heart failure (ICD-10 I50.1–I50.9). These are the exact diagnosis codes attached to CPB 0820. If your physician is implanting a Barostim device in a heart failure patient and billing to Aetna, you're looking at a claim denial on every line — device, lead, and pulse generator.
There is one narrow exception in the policy, and your team should know it precisely. Aetna covers removal of an implanted device when the patient has significant symptoms from the device itself — pain or infection are the cited examples. However, Aetna will not cover replacement of the same investigational device after removal. Removal for medical complication: covered. Removal and swap for a new unit: not covered.
This creates a billing scenario your team needs to handle carefully. CPT 0269T (revision or removal, total system) and CPT 0270T (revision or removal, lead only) are listed as non-covered in CPB 0820. But the policy text carves out removal for complications. If you're billing removal due to infection or pain, document that indication thoroughly. You may need to appeal with clinical notes to get payment, since the code-level table lists these as non-covered by default.
Talk to your compliance officer before billing removal claims. The carve-out is there, but the code classification doesn't automatically reflect it. That gap between the narrative policy and the code-level grouping is exactly the kind of inconsistency that leads to lost revenue or improper claims if you don't handle it intentionally.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Hypertension (all types) — Barostim neo™ System | Not Covered / Experimental | 0266T–0273T, 64654–64659, C1825, I10–I16.9 | Effectiveness not established per Aetna |
| Hypertension — Rheos Baroreflex Hypertension Therapy System | Not Covered / Experimental | 0266T–0273T, 64654–64659, C1825, I10–I16.9 | Explicitly named device; same exclusion applies |
| Heart failure (all ICD-10 I50.x codes) | Not Covered / Experimental | 0266T–0273T, 64654–64659, C1825, I50.1–I50.9 | Off-label use also excluded |
| All non-covered CPT codes (including percutaneous electrical nerve field stimulation) | Not Covered / Experimental | 0266T–0273T, 64654–64659, C1825 | CPB 0820 does not explicitly assign individual codes to specific device narratives; see code table for source descriptions |
| Device removal for pain or infection | Covered (with documentation) | 0269T, 0270T, 0271T, 64658, 64659 | Narrow exception — must document clinical indication; replacement of device post-removal is not covered |
Aetna Carotid Sinus Stimulation Billing Guidelines and Action Items 2026
| # | Action Item |
|---|---|
| 1 | Update your charge master now. Flag CPT codes 0266T, 0267T, 0268T, 0269T, 0270T, 0271T, 0272T, 0273T, 64654, 64655, 64656, 64657, 64658, and 64659, plus HCPCS C1825, as non-covered under Aetna before March 4, 2026. If you haven't done this yet, do it today. Every claim submitted after the effective date without this flag risks a denial you can't easily appeal. |
| 2 | Consult your payer contract before submitting any authorization requests for implantation codes. CPB 0820 classifies CPT 0266T (total system implantation), 0267T (lead only), and 0268T (pulse generator only) as experimental and investigational. Talk to your compliance team about how your Aetna contract handles authorization workflows for procedures in this category. If a physician still wants to proceed, your billing team should be part of that conversation early — the patient may be a self-pay candidate for this procedure. |
| 3 | Create a separate workflow for removal claims. If you bill CPT 0269T, 0270T, 0271T, 64658, or 64659 for device removal due to patient-reported pain or documented infection, treat these as appeals from the start. Attach clinical notes, physician attestation of the complication, and a written explanation that the removal is for a covered indication under CPB 0820's exception language. Don't submit bare claims and expect them to process cleanly. |
| 4 | Do not bill replacement procedures after removal. Aetna is explicit: replacing an investigational device after removal is not covered. If a physician removes a Barostim device and wants to implant a new one, that second implantation will be denied. Make sure your cardiology and cardiac surgery teams know this before they schedule the procedure. A denial after the fact is harder to resolve than a conversation before scheduling. |
| 5 | Audit open Aetna claims for these codes. Pull any pending or recently submitted claims that include CPT 64654–64659 or 0266T–0273T against Aetna payer IDs. If any were submitted before you reviewed this update, check denial status now. For claims already denied as experimental, review whether the clinical notes support an appeal under the removal-for-complication exception. |
| 6 | Brief your cardiology billing team on the ICD-10 scope. The entire I10–I16.9 hypertension range and all I50.x heart failure codes are tied to this non-coverage determination. If a cardiologist is considering BAT as a treatment option for a patient with either condition, your billing team should be part of that conversation before the procedure is scheduled — not after. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Carotid Sinus Stimulation Under CPB 0820
Not Covered / Experimental CPT Codes
All 14 CPT codes under CPB 0820 carry the same status: not covered for any indication listed in this policy bulletin.
| Code | Type | Description | Status |
|---|---|---|---|
| 0266T | CPT | Implantation or replacement of carotid sinus baroreflex activation device; total system (includes generator and lead) | Not Covered / Experimental |
| 0267T | CPT | Implantation or replacement of carotid sinus baroreflex activation device; lead only (includes intraoperative testing) | Not Covered / Experimental |
| 0268T | CPT | Implantation or replacement of carotid sinus baroreflex activation device; pulse generator only (includes intraoperative testing) | Not Covered / Experimental |
| 0269T | CPT | Revision or removal of carotid sinus baroreflex activation device; total system (includes generator and lead) | Not Covered / Experimental* |
| 0270T | CPT | Revision or removal of carotid sinus baroreflex activation device; lead only (includes intraoperative testing) | Not Covered / Experimental* |
| 0271T | CPT | Revision or removal of carotid sinus baroreflex activation device; pulse generator only (includes intraoperative testing) | Not Covered / Experimental* |
| 0272T | CPT | Interrogation device evaluation (in person), carotid sinus baroreflex activation system, including telemetric interrogation | Not Covered / Experimental |
| 0273T | CPT | Interrogation device evaluation (in person), carotid sinus baroreflex activation system, including telemetric interrogation, with physician analysis, review and report | Not Covered / Experimental |
| 64654 | CPT | Initial open implantation of baroreflex activation therapy (BAT) modulation system, including lead placement and intraoperative testing | Not Covered / Experimental |
| 64655 | CPT | Baroreflex activation therapy (BAT) modulation system; lead only | Not Covered / Experimental |
| 64656 | CPT | Revision or replacement of baroreflex activation therapy (BAT) modulation system, with intraoperative testing | Not Covered / Experimental |
| 64657 | CPT | Percutaneous electrical nerve field stimulation, cranial nerves, without implantation | Not Covered / Experimental |
| 64658 | CPT | Removal of baroreflex activation therapy (BAT) modulation system; lead only | Not Covered / Experimental* |
| 64659 | CPT | Removal of baroreflex activation therapy (BAT) modulation system; pulse generator only | Not Covered / Experimental* |
*Removal codes (0269T, 0270T, 0271T, 64658, 64659) may be covered when removal is performed for significant device-related symptoms (pain, infection). Replacement of the removed device is not covered. Document clinical indication thoroughly before billing.
Not Covered / Experimental HCPCS Codes
| Code | Type | Description | Status |
|---|---|---|---|
| C1825 | HCPCS | Generator, neurostimulator (implantable), non-rechargeable with carotid sinus baroreceptor stimulation | Not Covered / Experimental |
Key ICD-10-CM Diagnosis Codes Under CPB 0820
| Code | Description |
|---|---|
| I10–I16.9 | Hypertensive diseases (full range) |
| I50.1 | Heart failure |
| I50.2 | Heart failure |
| I50.3 | Heart failure |
| I50.4 | Heart failure |
| I50.5 | Heart failure |
| I50.6 | Heart failure |
| I50.7 | Heart failure |
| I50.8 | Heart failure |
| I50.9 | Heart failure |
CPB 0820 lists these codes with the description "Heart failure" only. Subcategory specificity (systolic, diastolic, etc.) is not defined in the source policy. Consult the ICD-10-CM code set directly for subcategory detail.
Get the Full Picture for CPT 64654
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.